We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+17.41%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$595M
AUM Growth
+$80.2M
Cap. Flow
+$9.15M
Cap. Flow %
1.54%
Top 10 Hldgs %
24.78%
Holding
215
New
32
Increased
102
Reduced
64
Closed
13

Sector Composition

Rank Sector Weight
1 Technology 16.08%
2 Healthcare 14.17%
3 Financials 9.45%
4 Industrials 8.89%
5 Communication Services 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOW icon
26
Lowe's Companies
LOW
$121B
$7.71M 1.3%
48,041
-410
-0.8% -$66.6K
NEE icon
27
NextEra Energy
NEE
$179B
$7.57M 1.27%
98,059
-2,729
-3% -$204K
AGG icon
28
iShares Core US Aggregate Bond ETF
AGG
$138B
$7.48M 1.26%
63,300
+44,856
+243% +$5.28M
LLY icon
29
Eli Lilly
LLY
$1.09T
$7.26M 1.22%
43,022
-928
-2% -$139K
MMM icon
30
3M
MMM
$94.8B
$7.14M 1.2%
48,866
+17,115
+54% +$2.43M
NXPI icon
31
NXP Semiconductors
NXPI
$58.9B
$6.74M 1.13%
42,415
+1,048
+3% +$154K
KO icon
32
Coca-Cola
KO
$373B
$6.63M 1.11%
120,902
+4,375
+4% +$226K
IJR icon
33
iShares Core S&P Small-Cap ETF
IJR
$112B
$6.58M 1.11%
71,545
+31,166
+77% +$2.56M
TMO icon
34
Thermo Fisher Scientific
TMO
$223B
$6.25M 1.05%
13,422
-208
-2% -$97.5K
ADBE icon
35
Adobe
ADBE
$103B
$5.98M 1%
11,954
+944
+9% +$456K
TER icon
36
Teradyne
TER
$63B
$5.88M 0.99%
49,049
-6,522
-12% -$666K
NVDA icon
37
NVIDIA
NVDA
$5.43T
$5.79M 0.97%
443,160
-96,800
-18% -$1.3M
INTC icon
38
Intel
INTC
$509B
$5.36M 0.9%
107,481
+14,664
+16% +$716K
ZTS icon
39
Zoetis
ZTS
$30.4B
$5.33M 0.9%
32,214
-4,107
-11% -$668K
WMT icon
40
Walmart Inc
WMT
$923B
$5.15M 0.86%
107,103
-17,442
-14% -$847K
MRK icon
41
Merck
MRK
$328B
$5.01M 0.84%
64,138
+947
+1% +$72.4K
NBIX icon
42
Neurocrine Biosciences
NBIX
$15.9B
$4.97M 0.84%
51,876
-6,198
-11% -$599K
ESGD icon
43
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
$4.83M 0.81%
66,090
+16,311
+33% +$1.11M
IGSB icon
44
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$4.81M 0.81%
87,230
-101,957
-54% -$5.61M
VRTX icon
45
Vertex Pharmaceuticals
VRTX
$133B
$4.69M 0.79%
+19,829
New +$4.55M
ILF icon
46
iShares Latin America 40 ETF
ILF
$3.71B
$4.46M 0.75%
+151,948
New +$3.83M
SPGI icon
47
S&P Global
SPGI
$121B
$4.36M 0.73%
13,256
-5,000
-27% -$1.69M
CSCO icon
48
Cisco
CSCO
$488B
$4.22M 0.71%
94,263
-17,678
-16% -$727K
ESGU icon
49
iShares ESG Aware MSCI USA ETF
ESGU
$18.4B
$4.21M 0.71%
48,883
+3,852
+9% +$313K
PSX icon
50
Phillips 66
PSX
$90B
$4.06M 0.68%
58,024
+5,620
+11% +$330K

Similar funds

Greenwood Capital Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Greenwood Capital Associates held 215 positions worth $595M, up 16% from $515M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Greenwood Capital Associates's Q4 2020 filing shows 32 new, 102 increased, 64 reduced and 13 closed positions. Its largest new stake was Vertex Pharmaceuticals: 19,829 shares worth $4.69M. The largest sale was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $5.61M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Greenwood Capital Associates's largest Q4 2020 buy was Vertex Pharmaceuticals: 19,829 shares worth $4.69M.
  • Greenwood Capital Associates added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $7.87M increase.
  • Greenwood Capital Associates's biggest Q4 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $5.61M.
  • Greenwood Capital Associates fully exited Akamai in Q4 2020, selling an estimated $4.4M.
  • Greenwood Capital Associates's ten largest holdings make up 25% of its $595M portfolio in Q4 2020.
  • Greenwood Capital Associates opened 32 new positions and closed 13 in Q4 2020.
  • Greenwood Capital Associates's portfolio value rose 16% quarter-over-quarter to $595M.

Based on Greenwood Capital Associates's 13F filing for Q4 2020, filed 9 Feb 2021.